Health Condition 1: J069- Acute upper respiratory infection,unspecified
Conditions
Interventions
Intervention1: Individualized Homeopathic
Medicines (IHMs) in lower
potencies (6CH or 12CH) of
centesimal scale: Intervention is planned as
administering the indicated
homeopathic medicines in desired
dosage and
repetition depending upon the
individual requirement of the
cases. All medicines will be
procured from a Good
Manufacturing Practice
(GMP)-certified firm. Study
subjects will be advised to
dosage and repetition depending upon the individual requirement of the cases. All medicines will be procured from a Good Manufacturing Practice
(GMP)-cer
Sponsors
Nehru Homoeopathic Medical College & Hospital, Govt. of NCT of Delhi
D N De Homoeopathic Medical College and Hospital Govt of West Bengal
Dr B R Sur Homoeopathic Medical College Hospital and Research Centre Govt of NCT of Delhi
Eligibility
Inclusion criteria
Inclusion criteria: 1. Children of age group 3-11 years 2. Patients of either sex 2. Clinical signs and symptoms of an URTI with a duration of 24 hours or more with or without fever >=37.5áµ?C 3. At least 1 of 3 types of URTI symptoms â?? nasal (plugged nose, runny nose, sneezing), pharyngeal (scratchy throat, sore throat, pharyngeal hyperemia), and cough (ordinary cough without suspicion of acute lower respiratory tract disease) 4. At least 1 of 5 general symptoms â?? feeling tired, weakness, body ache, irritable or whiney, or less active. 5. Literate guardians or attendants capable of understanding and filling the WURSS-21, CARIFS and URI-SSS questionnaires in local vernaculars, i.e., Bengali, Hindi and/or English.
Exclusion criteria
Exclusion criteria: 1. Severe or complicated course of URTI â?? bronchitis, pneumonia, sinusitis, otitis media, coinfection with bacterial agents, and exacerbation of pre-existing medical conditions, particularly asthma and chronic obstructive pulmonary disease, meningitis and sepsis 2. Signs of acute LRTI 3. COVID-19 positive cases as diagnosed by rapid antigen kit or RT-PCR method 4. Current symptoms mainly induced by other acute ENT diseases 5. Daily use of antibiotics, steroids and cytotoxic agents 6. Vulnerable population â?? unconscious, non-ambulatory, too sick for consultation, differently abled, terminally or critically ill subjects 7. Diagnosed cases of uncontrolled or life-threatening illness affecting quality of life or any organ failure 8. Self-reported immune-compromised state (e.g., HIV) 9. Undergoing homeopathic treatment for any chronic disease(s) within last 6 months 10. Simultaneous participation in any other clinical trials
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Time (measured in days) to complete clinical recovery between groupsTimepoint: Baseline, 4 (±1) days, 8 (±1) days & 15 (±2) days | — |
Secondary
| Measure | Time frame |
|---|---|
| Canadian Acute Respiratory Illness & Flu Scale (CARIFS) scoresTimepoint: Baseline, 4 (±1) days, 8 (±1) days, & 15 (±2) days;URI Symptom Severity Scale (URI-SSS) scoresTimepoint: Baseline, 4 (±1) days, 8 (±1) days, & 15 (±2) days;Wisconsin Upper Respiratory Symptom Survey (WURSS-21) scoreTimepoint: Baseline, 4 (±1) days, 8 (±1) days, & 15 (±2) days | — |
Countries
India
Contacts
Public ContactSubhranil Saha
D N De Homoeopathic Medical College and Hospital Kolkata OPD PG3
Outcome results
None listed